#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neutropenia Ocular lymphoma Acute myeloid leukaemia (in remission) Philadelphia chromosome positive Oesophageal atresia Alpha-1 antitrypsin deficiency Chronic lymphocytic leukaemia refractory Cervix carcinoma recurrent Glomerulonephritis Amyotrophic lateral sclerosis Fragile X syndrome Congenital aplastic anaemia Nodal marginal zone B-cell lymphoma Spinal cord injury Desmoplastic small round cell tumour More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Treatment Retinoblastoma – Diagnostics Leiomyosarcoma recurrent Hepatoblastoma – Diagnostics Pleural mesothelioma malignant – Trials in Disease Langerhans cell sarcoma – Trials in Disease Short-bowel syndrome Cytokine release syndrome – Basic Information Retinoblastoma – Treatment Lysosomal storage disorder – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    F44/10 Radium Ra 223 Dichloride Rbd5044 Sodium Cendakimab [14C]ZIPALERTINIB Tofogliflozin Doxycycline Gskvx000000009151 Rizolipase Piperacillin Monohydrate Sodium Chloride Solution 0.9% Avacincaptad Pegol Tirbanibulin Phenol, Liquefied Methotrexate Avibactam Carcik-Cd19 Cells Dcc-3116 Ro7589655 Aptamer-4Ft More therapies…

    Learn about Your Condition

    Bladder cancer stage III Paedophilia Strongyloidiasis Guttate psoriasis Primary amyloidosis Meniscus injury Blood iron increased Tertiary adrenal insufficiency Angiosarcoma non-metastatic Pertussis Anal cancer recurrent Cardiac valve disease Post procedural complication Macular oedema Oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colitis ulcerative

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vixarelimab
    • Adalimumab
    • Azathioprine
    Belgium Czechia France Germany Greece Italy +1

  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia France +8

  • A study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Vitiligo
    • Alopecia areata
    • Rheumatoid arthritis
    Belgium

  • Study of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Risankizumab
    Austria Bulgaria Croatia Czechia Estonia Finland +14
Previous Page
1 … 9 10 11 12 13 … 20
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!